Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia

Clinical significance of dasatinib-induced pleural effusion in patients with de novo chronic myeloid leukemia

Dasatinib is currently approved for clinical use as a first-line treatment agent for newly diagnosed chronic myeloid leukemia (CML). However, only a few clinical trials have been performed to evaluate dasatinibinduced PE following first-line therapy. We investigated the incidence and clinical featur...

Full description

Bibliographic Details
Main Authors: Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Format: Article
Language:English
Published: PAGEPress Publications 2018-09-01
Series:Hematology Reports
Subjects:
Chronic myeloid leukemia
Dasatinib
large granular lymphocyte
pleural effusion
late-onset
adverse event
Online Access:https://www.pagepress.org/journals/index.php/hr/article/view/7474

Internet

https://www.pagepress.org/journals/index.php/hr/article/view/7474

Similar Items